← Open Payments lookup

STEPHEN CASO: Open Payments

NPI 1083916985 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,365 in 85 payments from 28 companies in 2025. Trend: 2023 $2,270 · 2024 $2,939 · 2025 $2,365

Food & beverage: $2,365
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$323
Gilead Sciences, Inc.6$265
GlaxoSmithKline, LLC.8$218
Lilly USA, LLC7$205
Amgen Inc.5$202
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$136
Novo Nordisk Inc6$127
Inspire Medical Systems, Inc.2$114
Phadia US Inc.2$112
ABBVIE INC.4$67

Products named: TRELEGY ELLIPTA, MOUNJARO, XIFAXAN, BREZTRI, AIRSUPRA, INSPIRE, ImmunoCAP, FARXIGA.

Industry payments across CA — which companies pay providers there.